Correlation Between Keros Therapeutics and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and AnaptysBio, you can compare the effects of market volatilities on Keros Therapeutics and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and AnaptysBio.

Diversification Opportunities for Keros Therapeutics and AnaptysBio

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Keros and AnaptysBio is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and AnaptysBio go up and down completely randomly.

Pair Corralation between Keros Therapeutics and AnaptysBio

Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.41 times more return on investment than AnaptysBio. However, Keros Therapeutics is 2.42 times less risky than AnaptysBio. It trades about -0.09 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.29 per unit of risk. If you would invest  5,799  in Keros Therapeutics on August 24, 2024 and sell it today you would lose (415.00) from holding Keros Therapeutics or give up 7.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Keros Therapeutics  vs.  AnaptysBio

 Performance 
       Timeline  
Keros Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Keros Therapeutics and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Keros Therapeutics and AnaptysBio

The main advantage of trading using opposite Keros Therapeutics and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Keros Therapeutics and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements